Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine (Q38458874)

From Wikidata
Jump to navigation Jump to search
scientific article published on December 2007
edit
Language Label Description Also known as
English
Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine
scientific article published on December 2007

    Statements

    Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine (English)
    Stephen E Van Rompaey
    1 December 2007
    920-929

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit